ERDEM, S. Et Al. 2023. How important is upgrading on biochemical recurrence and prognosis after radical prostatectomy in low risk prostate cancer patients who are eligible for active surveillance?. 15th European Multidisciplinary Congress on Urological Cancers (EMUC) 2023 , (Marsilya, France), 100.

ERDEM, S., ERGÜL, R. B., ÇETİN, S., TANTEKİN, S. A., ÖZLÜK, M. Y., ŞANLI, M. Ö., ... ÖZCAN, F.(2023). How important is upgrading on biochemical recurrence and prognosis after radical prostatectomy in low risk prostate cancer patients who are eligible for active surveillance? . 15th European Multidisciplinary Congress on Urological Cancers (EMUC) 2023 (pp.100). Marsilya, France

ERDEM, Selçuk Et Al. "How important is upgrading on biochemical recurrence and prognosis after radical prostatectomy in low risk prostate cancer patients who are eligible for active surveillance?," 15th European Multidisciplinary Congress on Urological Cancers (EMUC) 2023, Marsilya, France, 2023

ERDEM, Selçuk Et Al. "How important is upgrading on biochemical recurrence and prognosis after radical prostatectomy in low risk prostate cancer patients who are eligible for active surveillance?." 15th European Multidisciplinary Congress on Urological Cancers (EMUC) 2023 , Marsilya, France, pp.100, 2023

ERDEM, S. Et Al. (2023) . "How important is upgrading on biochemical recurrence and prognosis after radical prostatectomy in low risk prostate cancer patients who are eligible for active surveillance?." 15th European Multidisciplinary Congress on Urological Cancers (EMUC) 2023 , Marsilya, France, p.100.

@conferencepaper{conferencepaper, author={Selçuk ERDEM Et Al. }, title={How important is upgrading on biochemical recurrence and prognosis after radical prostatectomy in low risk prostate cancer patients who are eligible for active surveillance?}, congress name={15th European Multidisciplinary Congress on Urological Cancers (EMUC) 2023}, city={Marsilya}, country={France}, year={2023}, pages={100} }